Omid (OMID, $0.03) was one of the top gainers for the month, rising to $0.03 per share. A.I.dvisor analyzed 244 stocks in the Pharmaceuticals: Other Industry for the month ending September 30, 2024 and discovered that of them (5) exhibited an Uptrend while of them (4) exhibited a Downtrend.